Wei‐Chun HuangFu

1.0k total citations
43 papers, 847 citations indexed

About

Wei‐Chun HuangFu is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Wei‐Chun HuangFu has authored 43 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Oncology. Recurrent topics in Wei‐Chun HuangFu's work include Histone Deacetylase Inhibitors Research (8 papers), Ubiquitin and proteasome pathways (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Wei‐Chun HuangFu is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Ubiquitin and proteasome pathways (5 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Wei‐Chun HuangFu collaborates with scholars based in Taiwan, United States and China. Wei‐Chun HuangFu's co-authors include Serge Y. Fuchs, Shiow‐Lin Pan, Kai‐Cheng Hsu, Juan Qian, Jianghuai Liu, Tony Eight Lin, Jing‐Ping Liou, Han-Li Huang, Min‐Wu Chao and I‐Hsuan Liu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Wei‐Chun HuangFu

40 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Chun HuangFu Taiwan 18 459 184 173 88 85 43 847
Shouyue Zhang China 20 736 1.6× 98 0.5× 172 1.0× 92 1.0× 245 2.9× 34 1.2k
Jaulang Hwang Taiwan 17 594 1.3× 145 0.8× 388 2.2× 109 1.2× 69 0.8× 34 1.0k
Sutapa Sinha United States 20 380 0.8× 248 1.3× 130 0.8× 37 0.4× 47 0.6× 43 908
Barbara Saxty United Kingdom 16 689 1.5× 111 0.6× 201 1.2× 81 0.9× 386 4.5× 33 1.1k
Anne Rascle Germany 20 716 1.6× 309 1.7× 278 1.6× 63 0.7× 111 1.3× 32 1.3k
Chunlai Nie China 22 796 1.7× 138 0.8× 293 1.7× 90 1.0× 134 1.6× 57 1.3k
Tianliang Li China 16 590 1.3× 268 1.5× 102 0.6× 50 0.6× 159 1.9× 40 875
Katelyn O’Neill United States 11 560 1.2× 162 0.9× 137 0.8× 16 0.2× 113 1.3× 15 813
Gabriela Galicia-Vázquez Canada 13 837 1.8× 369 2.0× 176 1.0× 37 0.4× 89 1.0× 16 1.3k
Linhui Zhai China 19 681 1.5× 71 0.4× 155 0.9× 31 0.4× 113 1.3× 48 941

Countries citing papers authored by Wei‐Chun HuangFu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chun HuangFu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chun HuangFu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chun HuangFu more than expected).

Fields of papers citing papers by Wei‐Chun HuangFu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chun HuangFu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chun HuangFu. The network helps show where Wei‐Chun HuangFu may publish in the future.

Co-authorship network of co-authors of Wei‐Chun HuangFu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chun HuangFu. A scholar is included among the top collaborators of Wei‐Chun HuangFu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chun HuangFu. Wei‐Chun HuangFu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chien‐Ju, et al.. (2025). Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals. Pharmaceutical Research. 42(1). 69–78. 6 indexed citations
2.
HuangFu, Wei‐Chun, Tony Eight Lin, Tzu-Ying Sung, et al.. (2024). Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma. International Journal of Biological Macromolecules. 283(Pt 1). 137296–137296. 1 indexed citations
3.
Chan, Tze‐Sian, Chung‐Chi Hsu, Pei‐Ming Yang, et al.. (2024). ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells. Molecular Oncology. 18(3). 562–579. 2 indexed citations
4.
Lin, Tony Eight, Wei‐Chun HuangFu, Jui‐Hua Hsieh, et al.. (2024). An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors. Protein Science. 33(6). e5007–e5007. 4 indexed citations
5.
Tu, Huang‐Ju, Tony Eight Lin, Zhaoxiang Peng, et al.. (2024). Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics. Biomedicine & Pharmacotherapy. 181. 117688–117688. 1 indexed citations
6.
Hwang, Tsong‐Long, Huang‐Ju Tu, Tony Eight Lin, et al.. (2024). Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor. International Journal of Biological Macromolecules. 282(Pt 4). 136860–136860.
7.
Wu, Yiwen, Wei‐Chun HuangFu, Tony Eight Lin, et al.. (2023). Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule. International Journal of Biological Macromolecules. 259(Pt 1). 129074–129074. 3 indexed citations
8.
Wu, Yiwen, Min‐Wu Chao, Huang‐Ju Tu, et al.. (2022). O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia. Phytomedicine. 100. 154061–154061. 7 indexed citations
9.
Chen, Liang‐Chieh, Wei‐Chun HuangFu, Yi‐Ying Chen, et al.. (2022). Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach. Bioorganic Chemistry. 121. 105675–105675. 14 indexed citations
10.
Lin, Tony Eight, Min‐Wu Chao, Wei‐Chun HuangFu, et al.. (2021). Identification and analysis of a selective DYRK1A inhibitor. Biomedicine & Pharmacotherapy. 146. 112580–112580. 11 indexed citations
11.
Chao, Min‐Wu, Tony Eight Lin, Wei‐Chun HuangFu, et al.. (2020). Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 98–108. 14 indexed citations
12.
HuangFu, Wei‐Chun, et al.. (2018). The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. PLoS neglected tropical diseases. 12(8). e0006715–e0006715. 63 indexed citations
13.
HuangFu, Wei‐Chun, et al.. (2018). Age, but not short-term intensive swimming, affects chondrocyte turnover in zebrafish vertebral cartilage. PeerJ. 6. e5739–e5739. 5 indexed citations
14.
Lin, Tony Eight, Wei‐Chun HuangFu, Min‐Wu Chao, et al.. (2018). A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions. Frontiers in Pharmacology. 9. 1379–1379. 31 indexed citations
15.
Chao, Min‐Wu, Han-Li Huang, Yu-Wei Chang, et al.. (2017). Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells. Scientific Reports. 7(1). 46134–46134. 35 indexed citations
16.
17.
Lee, Hsueh‐Yun, Sunil Kumar, Wei‐Chun HuangFu, et al.. (2016). 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity. European Journal of Medicinal Chemistry. 125. 1268–1278. 40 indexed citations
18.
Ding, Shih‐Torng, et al.. (2016). Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis. PLoS ONE. 11(12). e0167644–e0167644. 18 indexed citations
19.
HuangFu, Wei‐Chun & Serge Y. Fuchs. (2010). Ubiquitination-Dependent Regulation of Signaling Receptors in Cancer. Genes & Cancer. 1(7). 725–734. 38 indexed citations
20.
HuangFu, Wei‐Chun, Emily Omori, Shizuo Akira, Kunihiro Matsumoto, & Jun Ninomiya‐Tsuji. (2006). Osmotic Stress Activates the TAK1-JNK Pathway While Blocking TAK1-mediated NF-κB Activation. Journal of Biological Chemistry. 281(39). 28802–28810. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shouyue Zhang Breakdown of academic impact, for papers by Jaulang Hwang Breakdown of academic impact, for papers by Sutapa Sinha Breakdown of academic impact, for papers by Barbara Saxty Breakdown of academic impact, for papers by Anne Rascle Breakdown of academic impact, for papers by Chunlai Nie Breakdown of academic impact, for papers by Tianliang Li Breakdown of academic impact, for papers by Katelyn O’Neill Breakdown of academic impact, for papers by Gabriela Galicia-Vázquez Breakdown of academic impact, for papers by Linhui Zhai
Rankless by CCL
2026